Skip Nav Destination
Issues
1994
ISSN 0378-584X
EISSN 1423-0240
Journal Name Change
Continued with Vol. 37 (2014) as: Oncology Research and Treatment.
Onkologie 1994, Vol. 17, No. 3
Special Section
Impressum, Vol. 17, No. 3, 1994
Subject Area:
Oncology
Onkologie (1994) 17 (3): 205.
https://doi.org/10.1159/000218413
Inhalt, Vol. 17, No. 3, 1994
Subject Area:
Oncology
Onkologie (1994) 17 (3): 206.
https://doi.org/10.1159/000218414
Editorial
Tenth Anniversary of the Phase-ll Study Group in the Association for Medical Oncology (AIO) of the German Cancer Society
Subject Area:
Oncology
Onkologie (1994) 17 (3): 210.
https://doi.org/10.1159/000218415
Übersichtsarbeit – Review Article
Mediastinal Large B-Cell Lymphoma – A Distinct Entity among High-Grade Non-Hodgkin’s Lymphomas
Subject Area:
Oncology
Onkologie (1994) 17 (3): 212–215.
https://doi.org/10.1159/000218416
Treatment of Adult Soft-Tissue Sarcomas with Dose-Intensified Chemotherapy and Haematopoietic Growth Factors
Subject Area:
Oncology
Onkologie (1994) 17 (3): 216–225.
https://doi.org/10.1159/000218417
Interfering with Protein Kinase Cascades: Novel Mechanism for Anticancer Drugs
Subject Area:
Oncology
Onkologie (1994) 17 (3): 234–240.
https://doi.org/10.1159/000218419
Kurze Übersicht – Short Review
Angiosarcoma of the Breast
Subject Area:
Oncology
Onkologie (1994) 17 (3): 242–247.
https://doi.org/10.1159/000218420
Originalarbeit – Original Paper
Treatment Intensification with r-metHuG-CSF in High-Grade Malignant Non-Hodgkin’s Lymphomas
Subject Area:
Oncology
B. Steinke; A. Münz; Ch. Manegold; M. Freund; H.-M. Reinold; J.Th. Fischer; H. Arnold; E. Lengfelder; M. Lutz; T. Hecht; T. Zwingers
Onkologie (1994) 17 (3): 248–253.
https://doi.org/10.1159/000218421
Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer
Subject Area:
Oncology
Onkologie (1994) 17 (3): 263–269.
https://doi.org/10.1159/000218423
Clinical Assessment of the New Tumor Marker TPS
Subject Area:
Oncology
Onkologie (1994) 17 (3): 270–276.
https://doi.org/10.1159/000218424
Fax-Kommunikation – Fax Communication
llmofosine (BM 41.440) in Renal Cell Cancer – A Multicenter Phase II Study
Subject Area:
Oncology
Onkologie (1994) 17 (3): 278–279.
https://doi.org/10.1159/000218425
Further Section
Briefe an die Herausgeber – Letters to the Editors
Subject Area:
Oncology
Onkologie (1994) 17 (3): 284–286.
https://doi.org/10.1159/000218427
Kongressberichte – Congress Reports
Subject Area:
Oncology
Onkologie (1994) 17 (3): 288–290.
https://doi.org/10.1159/000218428
Klinische Information – Clinical Information
Konsensus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon- und Rektumkarzinom vom 11.3.1994
Subject Area:
Oncology
Onkologie (1994) 17 (3): 291–293.
https://doi.org/10.1159/000218429
Zur Rolle der Chemotherapie beim nichtkleinzelligen Bronchialkarzinom (NSCLC) im Tumorstadium III
Subject Area:
Oncology
Onkologie (1994) 17 (3): 294–302.
https://doi.org/10.1159/000218430
Further Section
Buchbesprechung – Book Review
Subject Area:
Oncology
Onkologie (1994) 17 (3): 303.
https://doi.org/10.1159/000218431
Industrieforum – Industrial Forum
Subject Area:
Oncology
Onkologie (1994) 17 (3): 304.
https://doi.org/10.1159/000218432
Anhang
Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft
Subject Area:
Oncology
W.E. Berdel; R. Becher; L. Edler; A.-R. Hanauske; S. Kerpel-Fronius; W. Rauschning; H.-J. Schmoll; H. Sindermann
Onkologie (1994) 17 (3): 311–338.
https://doi.org/10.1159/000218434
Further Section
Hinweise für Autoren – Instructions to Authors
Subject Area:
Oncology
Onkologie (1994) 17 (3): 339–340.
https://doi.org/10.1159/000218435
